Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. VYNE Therapeutics Inc.
  6. Consensus
    VYNE   US92941V2097

VYNE THERAPEUTICS INC.

(VYNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on VYNE THERAPEUTICS INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) VYNE THERAPEUTICS INC.
Analyst Recommendations on VYNE THERAPEUTICS INC.
2021HC Wainwright Assumes VYNE Therapeutics at Buy with $7 Price Target
MT
2021VYNE THERAPEUTICS : Northland Adjusts VYNE Therapeutics' Price Target to $6 From $12, Keeps Outperform Rating
MT
2021VYNE THERAPEUTICS : HC Wainwright Adjusts VYNE Therapeutics' Price Target to $11 from $14, Keeps Buy Rating
MT
2021VYNE THERAPEUTICS : Barclays Adjusts Price Target for VYNE Therapeutics to $15 From $12, Maintains Overweight ..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 0,64 $
Average target price 5,80 $
Spread / Average Target 800%
High Price Target 10,00 $
Spread / Highest target 1 453%
Low Price Target 3,00 $
Spread / Lowest Target 366%
Consensus detail
Consensus revision (last 18 months)